AbbVie vs Johnson & Johnson stock comparison
Score, categories, valuation, dividend, crash risk and price performance of AbbVie and Johnson & Johnson side by side. Figures from the overnight run, closing prices from 13 Nov 2026.
Key figures compared
| ABBVAbbVie | JNJJohnson & Johnson | |
|---|---|---|
| MEQIRI Score | ||
| Score | 74 | 75 |
| Fundamentals | 100 | 97 |
| Growth | 62 | 45 |
| Profitability | 88 | 85 |
| Valuation | 31 | 16 |
| Technical analysis | 82 | 83 |
| Momentum | 83 | 94 |
| Stability | 53 | 82 |
| Capital allocation | 69 | 83 |
| Price and valuation | ||
| Closing price | $295.03 | $285.75 |
| Market cap | $521.5B | $687.89B |
| P/E | 50.6 | 43.5 |
| Forward P/E | 18.4 | 24.8 |
| Fair value | $274.22 | $182.38 |
| Fair value versus price | −7.1% | −36.2% |
| Growth and dividend | ||
| Revenue growth per year | +6.0% | +6.3% |
| Dividend yield | 2.4% | 1.9% |
| Risk and performance | ||
| Crash risk | low4 in 100 | low4 in 100 |
| Price 1 year | +27.0% | +46.4% |
| Price 5 years | +152.2% | +73.2% |
| Industry | Drug Manufacturers (General) | Drug Manufacturers (General) |
Score and figures from the overnight run, closing prices from 13 Nov 2026. Amounts in US dollars, converted at the ECB rate. Price performance without dividends. The comparison shows figures and is not a recommendation to buy.
Price performance
- AbbVie
- Johnson & Johnson
All lines start at 100 on 19 November 2021. Closing prices without dividends, each stock in its trading currency.
Questions and answers
How do AbbVie and Johnson & Johnson compare on the MEQIRI Score?
The MEQIRI Score (0 to 100) is 74 for AbbVie and 75 for Johnson & Johnson. The category Stability differs most, with 53 for AbbVie and 82 for Johnson & Johnson. The score combines eight categories and is recalculated every night.
What is the P/E ratio of AbbVie and Johnson & Johnson?
AbbVie: P/E 50.6, forward P/E 18.4. Johnson & Johnson: P/E 43.5, forward P/E 24.8. As of the close on 13 Nov 2026.
What is the dividend yield of AbbVie and Johnson & Johnson?
AbbVie: 2.4%. Johnson & Johnson: 1.9%. Based on payments over the last twelve months.
What is the crash risk of AbbVie and Johnson & Johnson?
AbbVie: Crash risk low (4 in 100). Johnson & Johnson: Crash risk low (4 in 100). Crash risk means a fall of 30% or more within a year, measured in the backtest against companies of similar size.
Why does the price chart start at 100?
All lines start at 100 on the same day. That shows performance regardless of a stock's price: 150 means 50% more than at the start, 80 means 20% less.
Does the comparison tell me which stock to buy?
No. MEQIRI shows figures and explains them, but gives no buy recommendation and no price target. The score helps you see strengths and weaknesses faster.